Jefferies soars on Leucadia takeover


Deal Values Firm at $3.6 Billion

Leucadia National is buying the 71 percent of Jefferies Group that it didn't previously own in a deal valuing the securities firm at $3.6 billion. JEF is surging 20 percent before the bell on my tradeMONSTER platform.

Gilead Climbs on Hepatitis C Data

Gilead Sciences reported that patients taking its GS-5885 compound in combination with another drug had a 100 percent cure rate for hepatitis C. The trial was in Phase 2 of the testing process and only covered was on a small number of patients, but it's still sending GILD higher by 10 percent in early trading.

D.R. Horton Earnings Beat the Street

D.R. Horton reported fourth-quarter profit of $0.30, better than the $0.28 consensus estimate. Revenue of $1.3 billion missed expectations, but investors are focusing on that earnings beat and DHI is up more than 3 percent in the premarket.

More From optionMONSTER
View Comments (0)